A comprehensive view of Oral Medicines / Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

INTERNATIONAL PATENT: SIEMENS HEALTHCARE DIAGNOSTICS INC. FILES APPLICATION FOR "METHOD AND DEVICE FOR DETERMINING ONSET OF SEPSIS IN EMERGENCY SET-UPS"

Pfizer launches Phase 1 clinical trial to evaluate oral PF-07293893 on skeletal muscle biomarkers in 60 healthy adult participants in the US; the drug is being studied as possible treatment for heart disease

INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "ORAL FORMULATION OF N-PYRIDINYL ACETAMIDE DERIVATIVE FOR TREATING INTERSTITIAL LUNG DISEASE"

Cipla recalls 59,244 packs of Ipratropium Bromide and Albuterol Sulfate inhalation solution, Glenmark recalls 3,264 bottles of Diltiazem Hydrochloride extended-release capsules; Lupin recalls 26,352 bottles of Rifampin capsules

Biopharmaceutical firm Alkermes concludes the sale of its development and manufacturing facility in Athlone, Ireland, to Novo Nordisk for US$91.0M; the plant provides Novo Nordisk with additional development and manufacturing capacity for oral products

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count